Quantinno Capital Management LP Buys 51,275 Shares of The Chemours Company $CC

Quantinno Capital Management LP lifted its stake in The Chemours Company (NYSE:CC) by 16.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 364,745 shares of the specialty chemicals company’s stock after acquiring an additional 51,275 shares during the quarter. Quantinno Capital Management LP owned approximately 0.24% of Chemours worth $8,035,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CC. Atlas Capital Advisors Inc. acquired a new position in shares of Chemours during the 4th quarter worth approximately $26,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Chemours in the 4th quarter valued at approximately $28,000. Covestor Ltd grew its stake in shares of Chemours by 204.7% in the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after buying an additional 1,748 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new position in shares of Chemours in the fourth quarter valued at $31,000. Finally, Rothschild Investment LLC increased its holdings in Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after buying an additional 1,255 shares during the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have commented on CC. Truist Financial increased their price target on shares of Chemours from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. UBS Group upped their target price on shares of Chemours from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, May 8th. Royal Bank Of Canada raised their target price on shares of Chemours from $26.00 to $29.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Alembic Global Advisors reissued an “overweight” rating and set a $30.00 price target on shares of Chemours in a research report on Wednesday, May 13th. Finally, Morgan Stanley raised their price objective on Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $24.10.

More Chemours News

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours generated $158 million in operating cash flow and $114 million in free cash flow during the second quarter. Titanium Technologies sales also increased 1% year over year, while the company cited growth opportunities tied to data-center demand. Chemours reports second-quarter sales and loss
• Positive Sentiment: Management maintained its 2026 outlook for 1% to 5% sales growth and adjusted EBITDA of $775 million to $825 million. Full-year revenue guidance of $5.9 billion to $6.1 billion is broadly in line with consensus. Chemours reports second-quarter results
• Neutral Sentiment: The board declared a quarterly dividend of $0.0875 per share, providing continued shareholder income but offering limited evidence of improving operating performance. Chemours announces third-quarter dividend
• Negative Sentiment: Second-quarter adjusted EPS was $0.42, below the $0.43 Zacks consensus and other analyst estimates near $0.50; earnings also declined from $0.58 a year earlier. Revenue fell 1% to $1.591 billion, and adjusted EBITDA decreased to $247 million from $260 million. Chemours misses second-quarter earnings and revenue estimates
• Negative Sentiment: Chemours reported a $274 million GAAP net loss, or $1.81 per share, with litigation costs weighing on results and overshadowing otherwise favorable data-center growth. Third-quarter revenue guidance of $1.5 billion to $1.6 billion is below the $1.6 billion consensus, reinforcing near-term execution concerns. Chemours litigation costs overshadow data-center growth

Chemours Stock Performance

NYSE CC opened at $17.94 on Wednesday. The stock has a market cap of $2.70 billion, a PE ratio of -6.80 and a beta of 1.43. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.87 and a current ratio of 1.82. The firm has a 50-day moving average of $19.67 and a 200-day moving average of $20.06. The Chemours Company has a 52-week low of $10.44 and a 52-week high of $28.67.

Chemours (NYSE:CC) last announced its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.08). The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.65 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The firm’s quarterly revenue was down 1.5% on a year-over-year basis. During the same quarter last year, the company posted ($2.54) EPS. On average, sell-side analysts anticipate that The Chemours Company will post 1.18 EPS for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 14th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 annualized dividend and a dividend yield of 2.0%. Chemours’s dividend payout ratio is presently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.